InvestorsHub Logo
Followers 1
Posts 114
Boards Moderated 0
Alias Born 06/07/2023

Re: DC15 post# 2584

Friday, 07/07/2023 2:37:34 PM

Friday, July 07, 2023 2:37:34 PM

Post# of 3059
...as Enanta broadens its modalities of focus into the immunology therapeutic area.

I felt it was important that I support my use of the word "immunotherapy" so I am providing the above statement as declared on the job description. Growth or a jump, you choose.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News